The US Food and Drug Administration's response to the COVID-19 pandemic makes for a long list of topics to discuss. In remarks at a regulatory conference, acting Commissioner Janet Woodcock noted the FDA’s work in the consumer health space near the top.
“The effort by the FDA’s workforce over the past year and a half has been nothing short of monumental,” Woodcock...





